Descubre y comparte nuestro conocimiento público

Se han encontrado 3 recursos

Resultados de búsqueda

A live, attenuated vaccine is currently the only viable option to control of CBPP in Africa. It has been suggested that simple modifications to current vaccines and protocols might improve efficacy in the field. In this report we compared the current vaccine formulation with a buffered preparatio...


Nkando, I.Ndinda, J.Kuria, J.Naessens, JanMbithi, F.Schnier, C.Gicheru, M.McKeever, Declan J.Wesonga, H.O.[Efficacy of two vaccine formulations against contagious bovine pleuropneumonia (CBPP) in Kenyan indigenous cattle]Efficacy of two vaccine formulations against contagious bovine pleuropneumonia (CBPP) in Kenyan indigenous cattle

Abstract Contagious bovine pleuropneumonia (CBPP) is an economically important disease in most of sub-Saharan Africa. A conjoint analysis and ordered probit regression models were used to measure the preferences of farmers for CBPP vaccine and vaccination attributes. This was with regard to inclu...


Kairu-Wanyoike, S.W.Kaitibie, S.Taylor, N.M.Gitau, G.K.Heffernan, C.L.Schnier, C.Kiara, Henry K.Taracha, E.A.McKeever, Declan J.[Exploring farmer preferences for contagious pleuropneumonia vaccination: A case study in Narok district of Kenya]Exploring farmer preferences for contagious pleuropneumonia vaccination: A case study in Narok district of Kenya

Contagious bovine pleuropneumonia (CBPP) is a serious respiratory disease of cattle caused by Mycoplasma mycoides subsp. mycoides. Current vaccines against CBPP induce short-lived immunity and can cause severe postvaccine reactions. Previous studies have identified the N terminus of the transmemb...


Mulongo, M.Frey, J.Smith, K.Schnier, C.Wesonga, H.O.Naessens, JanMcKeever, Declan J.[Vaccination of cattle with the N terminus of LppQ of Mycoplasma mycoides subsp. mycoides results in type III immune complex disease upon experimental infection]Vaccination of cattle with the N terminus of LppQ of Mycoplasma mycoides subsp. mycoides results in type III immune complex disease upon experimental infection

Selecciona los documentos para visualizarlos

Nombre del archivo Ver recurso